Neurocrine Bioscience buy Bank of America Co.
Start price
07.02.25
/
50%
€125.40
Target price
07.02.26
€172.66
Performance (%)
-8.85%
Price
11:36
€114.30
Summary
This prediction is currently active. With a performance of -8.85%, the BUY prediction for Neurocrine Bioscience by Bank_of_America_Co_ is down slightly. This prediction currently runs until 07.02.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 0.399% | 0.399% |
| iShares Core DAX® | -0.121% | 2.507% |
| iShares Nasdaq 100 | 0.081% | -0.241% |
| iShares Nikkei 225® | -1.748% | 4.105% |
| iShares S&P 500 | -0.961% | -0.143% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at Bank of America Co. from $184.00 to $179.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat